{
  "abstract": "Globally, the burden of type 2 diabetes mellitus (T2DM) continues to rise, with implications on cardiovascular risk, metabolic liver disease and cancer incidence.1 Despite advances in pharmacological management, over 50% of patients do not achieve optimal glycaemic control (HbA1c<7%), and therefore alternate approaches remain necessary.",
  "authors": [
    {
      "affiliations": [
        "Department of Gastroenterology, Royal Cornwall Hospitals NHS Trust, Truro, UK",
        "Medical and Dental Sciences, University of Birmingham, Birmingham, UK, Birmingham, UK"
      ],
      "name": "Keith Siau"
    }
  ],
  "title": "PIMA facie evidence for endoscopic therapy in type 2 diabetes",
  "uid": "ba65a91f-90ab-50cf-bf24-165b38349ed8"
}